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The stereotypical pattern of neuroﬁbrillary tangle spreading in the earliest stages of typical Alzheimer’s
dementia (AD) predicts that medial perirhinal cortex (mPRC) atrophy precedes entorhinal cortex (ERC)
atrophy, whereas the status of the parahippocampal cortex (PHC) remains unclear. Atrophy studies have
focused on more advanced rather than early AD patients, and usually segment the entire PRC as opposed
to the mPRC versus lateral PRC (lPRC). The present study therefore determined the extent of ERC, mPRC,
lPRC, and PHC atrophy in very early AD (mean Mini-Mental State Examination score ¼ 26) patients and
its presumed prodrome amnestic mild cognitive impairment (mean Mini-Mental State Examination
score ¼ 28) compared to demographically matched controls. PHG structures were manually segmented
(blinded rater) and cortical thicknesses extracted. ERC and mPRC were similarly atrophied in both patient
groups. The lPRC was atrophied in the AD group only. Thus, atrophic changes in very early AD broadly
map onto the pattern of neuroﬁbrillary tangle spreading and suggest that mPRC, ERC, and lPRC, but not
PHC-associated functional impairments, characterize very early-stage AD.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The early stages of Alzheimer’s dementia (AD) are associated
with atrophy of the parahippocampal gyrus (PHG, i.e., entorhinal
cortex [ERC], perirhinal cortex [PRC] and parahippocampal cortex
[PHC]) of the medial temporal lobe (MTL). In typical AD, neuroﬁ-
brillary tau pathology begins in the transentorhinal cortex (i.e.,
medial PRC [mPRC]), from where it spreads to the ERCiversity Center for Medicine
CH-4031 Basel, Switzerland.
mm).
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Ltd, Grenzacherstrasse 124,
Inc. This is an open access article u(transentorhinal stages) and to the hippocampal subﬁelds (limbic
stages) before spreading into the lateral PRC (lPRC) and isocortical
structures (Braak and Braak, 1991; Braak and Del Tredici, 2006;
Kordower et al., 2001; Taylor and Probst, 2008). Most in-
vestigations of atrophy in AD or its putative prodrome amnestic
mild cognitive impairment (aMCI) focus on ERC and hippocampal
atrophy, but rarely on that of the PRC, in particular its medial
versus lateral aspects (e.g., Du et al., 2001). Also, it is unclear to
what extent the PHC is affected in the earliest stages of AD. Finally,
it remains unclear whether the brunt of PHG thinning is concen-
trated in speciﬁc anterior-to-posterior levels and, thus, which
corresponding coronal levels are optimally clinically informative
for distinguishing between healthy normal controls (NCs) and very
early AD patients. The present study addresses these questions by
manually segmenting the key PHG structures on high-resolution
magnetic resonance imaging (MRI) scans according to ander the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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protocol (Insausti et al., 1998; Kivisaari et al., 2013b; Taylor and
Probst, 2008) in a large group of healthy control subjects and
very early AD patients.
The progressive accumulation of neuroﬁbrillary tangles (NFTs) is
assumed to be causally related to cortical atrophy in AD (Ball, 1978;
Gómez-Isla et al., 1997). Pyramidal cells in the mPRC are the ﬁrst
cortical neurons to be affected by NFTs (stage I; Braak and Braak,
1991, 1995; Kordower et al., 2001). We note that the mPRC corre-
sponds to Braak and Braak (1991) “transentorhinal cortex” (Taylor
and Probst, 2008). Next, cells in layer II of the ERC are affected
before pathology spreads to the hippocampal formation (stage II)
and into layer IV of the ERC (stage III) (Braak and Del Tredici, 2006).
The lPRC is affected in stage III (Braak and Braak, 1991; Braak and
Del Tredici, 2006; Van Hoesen et al., 2000). If atrophy mainly re-
sults from tau pathology, this progression of pathology predicts that
cortical thinning of the mPRC precedes that of the lateral ERC.
However, this pattern may not be apparent on structural MRI, since
the involvement of a single cortical layer (e.g., mPRC stages I, II) may
not cause sufﬁcient cortical thinning for its detection on structural
MRI scans. That is, ERC atrophy may be visible on MRI before mPRC
atrophy, because 2 independent cortical layers of the ERC (i.e.,
layers II and IV) are affected early in the disease process compared
to a single mPRC layer. Moreover, it is unclear whether the PHC is
affected by the pathological tau accumulation in the earliest stages
of AD. This is a critical point, since early PHC atrophy could explain
some of the cognitive (e.g., visuospatial: Epstein and Kanwisher,
1998) impairments associated with early AD.
MRI-based studies of regional PHG integrity in mild-to-
moderate AD patients consistently report atrophy of these struc-
tures. Juottonen et al. (1998) compared the ERC, entire PRC, and
temporopolar cortex volumes of 30 AD patients (Mini-Mental State
Examination [MMSE; Folstein et al., 1975] range 14e28) with 32 NC
participants. They found that each region was signiﬁcantly atro-
phied in AD patients, with the ERC signiﬁcantly more severely
affected than the entire PRC. Similarly, Teipel et al. (2006) reported
comparable extents of atrophy when analyzing the volumes of the
entire PRC, PHC, and ERC of AD patients (n¼ 34; MMSE scores 10)
to NCs (n ¼ 22). Measures of cortical thickness may provide a more
accurate measure of atrophy than 3-dimensional volumes, espe-
cially in anatomically highly variable regions such as the PRC, where
volumetric measurements are confounded by the size of this
structure which varies widely between individuals according to the
depth and number of collateral sulci (CS; Insausti et al., 1998). Using
mean cortical thickness measurements, Lerch et al. (2005)
demonstrated severe cortical thinning of the entire PHG in 19 AD
patients (MMSE range, 10e29) compared to 17 NCs, with a signiﬁ-
cant group difference in the anterior portion of the left ERC, which
was the only cytoarchitectonic ﬁeld that was individually
segmented. Dickerson et al. (2009) segmented each PHG subﬁeld in
29 AD patients (MMSE range, 16e28) and found signiﬁcant cortical
thinning of the ERC, mPRC (estimated by the medial bank of the
collateral sulcus), and PHC compared to 47 NC participants. Taken
together, these studies demonstrate signiﬁcant and comparable
extents of atrophy in the ERC, PRC, and PHC in the mild-to-
moderate stages of AD.
The comparable degree of PHG atrophy reported in the afore-
mentioned studies does not at ﬁrst blush map onto the progression
of NFT pathology as described by Braak and Braak (1995). However,
the ADpatients investigatedwere either inmild-to-moderate stages
of the disease, or the samples were highly variable with respect to
disease stage (MMSE scores range from 10 to 29). Thus, neuroﬁ-
brillary pathology was presumably more dense and widespread
compared to patients in the early stages of the disease. Therefore,
very early AD patients who are expected to be in early stages of NFTpathology should be examined (Geddes et al., 1997; Nelson et al.,
2012). Second, it is essential to segment the mPRC from the lPRC,
as cortical NFT begins in themPRC (stage I), whereas the lPRC is only
affected by NFT in stage IV. The anatomic borders of the mPRC
corresponding to Braak and Braak’s “transentorhinal region” were
described by Taylor and Probst (2008) and subsequently integrated
into an MTL segmentation protocol (Kivisaari et al., 2013b) incor-
porating aspects of the Insausti et al. (1998) criteria. Given the high
anatomic variability of the CS, which deﬁnes mPRC and lPRC
boundaries, it is necessary to segment these structures manually to
achieve anatomic precision (Hanke, 1997; Pruessner et al., 2002).
The purpose of the present study was to adopt the approach
described previously to determine the location and extent of cortical
thinning in theERC,mPRC, lPRC, andPHC in2groups of patientswith
very early AD, that is, a group of aMCI patients presumed to be in the
prodromal phases of AD (Petersen et al., 2006), and a group ofmildly
affected AD patients. All regions of interest (ROIs) were manually
segmented by an investigator blinded to diagnosis (Sabine Krumm)
using an anatomical protocol recapitulated here (Kivisaari et al.,
2013b). Speciﬁcally, we aimed to determine whether, in the very
early stages of AD, (1) themPRC and/or ERC is signiﬁcantly atrophied
(1 vs. 2 layers) and (2) PHC thinning is apparent. The ﬁrst question
tests the hypothesis that cortical thinning maps onto the pattern of
neuroﬁbrillary pathology, and the second question addresses the
unknown status of the PHC in the earliest stages of AD. Both issues
are highly clinically relevant as theyadvise clinicians of the anatomic
structures to focus on during the diagnostic process and indicate
which corresponding cognitive impairments are expected in the
early stages of AD (see e.g., Kivisaari et al., 2012). Finally, we asked
whether (3) cortical thinning is maximized in speciﬁc anterior-to-
posterior coronal levels which would reﬂect the optimal slices on
which to clinically detect very early AD.2. Methods
2.1. Participants
Data from 121 native Swiss-German or German-speaking adults
were included in the present study: 64 healthy control participants
(NC) and 57 individuals with very early AD (see the following
paragraph). The healthy control participants had undergone a
thorough medical screening and neuropsychological testing to
ensure that they were cognitively (i.e., neurologically and psychi-
atrically) healthy. Speciﬁcally, exclusion criteria included severe
auditory, visual or speech deﬁcits; severe sensory or motor deﬁcits;
severe systemic disease; continuous mild-to-intense pain; diseases
with severe or probable impact on the central nervous system (e.g.,
neurologic disorders including cerebral-vascular disease, general-
ized atherosclerosis, and psychiatric problems); and intake of
potent psychoactive substances except mild tranquilizers. In addi-
tion, all NCs received normal scores on the MMSE (Folstein et al.,
1975), California Verbal Learning Task (Delis et al., 1987), Clock
Drawing Test (Critchley, 1953), and short version of the Boston
Naming Test (Kaplan et al., 1983).
Thirty-four participants (16 male, 18 female) were diagnosed
with AD according to NINCDS-ADRDA and DSM-IV criteria
(American Psychichiatric Association, 1994) and 23 patients (11
male, 12 female) with mild neurocognitive disorder because of AD
according to DSM-IV and Winblad et al. (2004) criteria ( aMCI;
single-, or multi-domain). All patients had been recruited from the
Memory Clinic, University Center for Medicine of Aging in Basel,
Switzerland, where they had received neuropsychological testing,
MRI scanning, and medical and neurological examinations
including blood analyses.
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matched to the aMCI group and AD patients with regard to age,
gender, and education (all p-values > 0.3; see Table 1). As expected,
mean MMSE scores of the aMCI and the AD groups signiﬁcantly
differed from their respective control groups (NC vs. aMCI: F(1,67)¼
8.55, p < 0.01; NC vs. AD: F(1,63) ¼ 47.19, p < 0.001). Critically, the
mean MMSE scores of both patients groups indicate that they were
mildly affected.
2.2. MRI measures
2.2.1. MRI acquisition
All participants received MRI scanning conducted on a 3-T head
scanner (MAGNETOM Verio, Siemens) at the University Hospital
Basel (T1-weighted 3D magnetization-prepared rapid acquisition
gradient echo; inversion time ¼ 1000 ms; repetition time ¼
2000ms; echo time¼ 3.75ms; ﬂip angle¼ 8; ﬁeld of view¼ 256
256; acquisition matrix ¼ 256  256 mm; voxel size ¼ 1 mm
isotropic).
2.2.2. Preprocessing of structural MR images
Preprocessing of MRI scans was conducted using FreeSurfer
(Massachusetts General Hospital, Boston, MA; http://surfer.nmr.
mgh.harvard.edu; Dale et al., 1999; Fischl and Dale, 2000).
Magnetization-prepared rapid acquisition gradient echo volumes
were semiautomatically segmented into gray and white matter and
the pial and gray/white matter surfaces were formed (Dale et al.,
1999). Tissue next to the anteromedial temporal lobe was
removed by hand because it interfered with the cortical surface
reconstructions. The cortical thickness is deﬁned as the distance
between corresponding vertices on the gray/white matter and pial
surfaces. The total intracranial volume (TIV; gray matter þ white
matter þ CSF volumes) per participant was estimated using SPM8
(Wellcome Institute of Cognitive Neurology) implemented in Mat-
lab 2010 (Mathworks Inc., Sherborn, MA, USA).
2.2.3. Regions of interest
To our knowledge, no available software accurately and auto-
matically segments the mPRC and lPRC on MRI images. However,
the creation of labels for these regions is necessary to extract
cortical thickness data. MTL ROIs were therefore manually drawn
by a blinded rater (Sabine Krumm) on coronal slices of the native
space cortical surface reconstructions generated by FreeSurfer ac-
cording to anatomic landmarks described in Kivisaari et al. (2013b)
which was based primarily on Insausti et al. (1998). We note that
the major deviation between the Insausti et al. (1998) and Kivisaari
et al. (2013b) protocols is the latter’s inclusion of landmarks to
segment the mPRC and lPRC based on Taylor and Probst (2008). Left
and right hemispheric ROIs were drawn for the mPRC, lPRC, ERC,
and PHC. The mPRC corresponds to the transentorhinal region,Table 1
Demographic characteristics and MMSE scores for the demographically matched NC
and aMCI and AD samples
Variable NC versus aMCI NC versus early AD
NC (n ¼ 46) aMCI (n ¼ 23) NC (n ¼ 31) Early AD (n ¼ 34)
Mean  SD Mean  SD Mean  SD Mean  SD
Age 74.78  7.09 76.08  8.26 78.10  5.58 78.89  5.24
Gendera 1.41  0.50 1.52  0.51 1.42  0.50 1.53  0.51
Education 13.41  3.10 14.00  3.66 12.55  2.46 12.24  3.04
MMSE score 29.26  1.10 28.22  1.86** 29.19  1.05 26.32  2.09**
Key: AD, Alzheimer’s dementia; aMCI, amnestic mild cognitive impairment; MMSE,
Mini-Mental State Examination; NC, normal controls; SD, standard deviation.
a _ ¼ 1; \ ¼ 2; signiﬁcant difference compared to respective NC group at **p <
0.01 (unpaired, 2-tailed t tests).considered as an area of transition between ERC and PRC (Braak and
Braak, 1985; Taylor and Probst, 2008). For the purposes of the
present study, only portions of the PRC lateral to the ERC were
segmented, that is, the most anterior and posterior aspects of the
PRC, which wrap medially around the most anterior and posterior
part of the ERC, were not segmented because to our knowledge no
cytoarchitectonic data exist to delineate the PRC subregions here
(Taylor and Probst, 2008). The detailed manual segmentation pro-
tocol is described in Table 2 [structured in the style of Pruessner
et al., (2002)]. We note that the proportions of shallow, normal,
and deep CS were comparable in the aMCI and the respective
control group (c2 ¼ 2.450, p ¼ 0.294), as were proportions of single
versus bifurcated CS in both patient groups (aMCI vs. NC: c2 ¼
0.579, p ¼ 0.447; AD vs. NC: c2 ¼ 0, p ¼ 1) and shallow, normal, and
deep bifurcated sulci (aMCI vs. NC: c2 ¼ 3.36, p ¼ 0.186; AD vs. NC:
c2¼ 0.087, p¼ 0.768). Alone the proportion of shallow, normal, and
deep CS signiﬁcantly differed between the AD and their NC group
(AD vs. NC: c2 ¼ 16.804, p < 0.001) as a consequence of the more
frequent occurrence of shallow CS in the AD group (AD vs. NC: 62%
vs. 36%), consistent with their atrophy and thus sulcal ﬂattening
(Im et al., 2008). However, we note that PRC cortical thickness
values are less susceptible to variations in CS depth compared to
“volumetric” measures (see the previously mentioned paragraphs).
2.2.4. Cortical thickness estimates
Three-dimensional measurements of atrophy in PHG regions
and especially the PRC, such as volumetric measures, depend on the
number and depth of the CS (i.e., deeper CS are associated with
more voluminous PRCs). To compare atrophy across ROIs while
controlling for intraindividual differences in the size of the PRCs, we
used a measure that is independent of volume (i.e., the depth of the
collateral sulcus), namely the cortical thickness of each manually
segmented ROI. Mean cortical thickness values for each ROI were
obtained using FreeSurfer (Massachusetts General Hospital, Boston,
MA; http://surfer.nmr.mgh.harvard.edu; Dale et al., 1999; Fischl and
Dale, 2000), and individual cortical thickness values for each vertex
were extracted using Matlab 2010 (Mathworks Inc., Sherborn, MA;
USA). By default, FreeSurfer sets the cortical thickness maximum to
5 mm because a former study demonstrated that this upper limit
included the large majority of cortical thickness estimates (Fischl
and Dale, 2000). However, 2.4% of our thickness values exceeded
the 5 mm maximum, resulting in a non-normal distribution.
Therefore, we changed this limit to 10 mm and visually inspected
the location of each vertex exceeding 5 mm. Two of 9384 vertices
were not lying within our ROIs and were therefore excluded; the
remaining vertices were included in the subsequent analyses. The
right-anterior-superior coordinates were converted into Montral
Neurological Institute (MNI) coordinates in FreeSurfer. Mean pa-
tient cortical thickness values were transformed into standard (z-)
scores for graphic visualization according to the following
formulae: ([mean patient cortical thickness value][corresponding
mean NC cortical thickness])/(corresponding NC standard deviation
of mean cortical thickness). Three-dimensional graphical de-
pictions of these vertex-wise mean cortical thickness z-scores
representing NC and patient differences in cortical thickness over
the cortical surface were plotted in Matlab 2010.
2.3. Statistical analyses
Cortical thickness estimates used in the statistical analyses were
normalized for head size (TIV; [(cortical thickness)/(TIV)]  100)
and retransformed into metric values (mm) for tabular reporting to
facilitate interpretation. To determine which demographic vari-
ables and whether hemisphere should be included as covariates in
the statistical analyses of group differences, we performed a
Table 2
Segmentation protocol for the mPRC, lPRC, ERC, and PHC (CS) based on structural MRI scans of 1 mm3 resolution
Structure Anterior border Posterior border Medial border Lateral border Comments
ERC 2 mm posterior to the ﬁrst
anterior slice where thewhite
matter of the limen insulae is
visible.
1 mm posterior to the last
slice still containing the apex
of the intralimbic gyrus.
Midpoint of the gyrus
ambiens. If not visible, the
shoulder of the superomedial
bank of parahippocampal
gyrus.
Shoulder of the medial bank
of the CS.
A CS is typically visibly at the
level of the anterior border.
However, in the sections
where the CS begins but is
not yet fully formed, the
border is estimated from
more posterior slices with an
obvious CS.
Medial PRC Same coronal level as the
anterior border of the ERC,
i.e., 2 mm posterior to the ﬁrst
anterior slice where thewhite
matter of the limen insulae is
visible.
1 mm posterior to the last
slice still containing the apex
of the intralimbic gyrus.
Shoulder of the medial bank
of the CS.
Small or regular CS (1.5 cm):
fundus of the CS. Deep CS
(>1.5 cm): midpoint between
shoulder of medial bank of CS
and midpoint of lateral bank
of CS.
If the CS is bifurcated, the
criteria apply to the most
medial sulcus.
Lateral PRC Same coronal level as the
anterior border of the ERC,
i.e., 2 mm posterior to the ﬁrst
anterior slice where thewhite
matter of the limen insulae is
visible.
1 mm posterior to the last
slice still containing the apex
of the intralimbic gyrus.
Small or regular CS
(1.5 cm): fundus of the CS.
Deep CS (>1.5 cm): midpoint
between shoulder of medial
bank of CS and midpoint of
lateral bank of CS.
Regular CS (1e1.5 cm):
shoulder of lateral bank of CS.
Shallow CS (<1 cm): midpoint
of fusiform gyrus. Deep CS
(>1.5 cm): midpoint between
CS fundus and shoulder of its
lateral bank.
If the CS is bifurcated, the
criteria apply to the most
medial sulcus.
PHC 4 mm posterior to the last
slice containing the apex of
the intralimbic gyrus.
First posterior slice where
the pulvinar is no longer
visible.
Medial apex of the
parahippocampal gyrus,
neighboring subiculum of the
hippocampus.
Regular CS (1e1.5 cm):
shoulder of lateral bank of CS.
Shallow CS (<1 cm): midpoint
of fusiform gyrus. Deep CS
(>1.5 cm): midpoint between
fundus and shoulder of lateral
bank of CS.
The PHC is considered the
posterior gyral continuation
of the combined PRC and
ERC.
This protocol segments the transentorhinal area of the PRC lateral to the ERC; therefore, the most anterior and posterior portions of the PRC wrapping around the ERC (e.g.,
3e4 mm posterior to the last slice still containing the apex of the intralimbic gyrus) were not included in the mPRC and lPRC ROIs.
Key: CS, collateral sulcus; ERC, entorhinal cortex; lPRC, lateral perirhinal cortex; mPRC, medial perirhinal cortex; MRI, magnetic resonance imaging; PHC, parahippocampal
cortex; ROI, region of interest.
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cortical thickness values of the entire NC group (n ¼ 64; mean age
[SD] ¼ 72.97 [7.15], 40 male, 24 female; mean education [SD] ¼
13.17 [3.05], mean MMSE score [SD] ¼ 29.19 [1.09]) as the
dependent variable; the hemispheres and the 4 ROIs as indepen-
dent variables; and sex, education, and age as covariates. Sex and
education were signiﬁcantly related to mean thickness values
[female>male; F(1, 501)¼ 72.454, p< 0.001; F(1, 501)¼ 5.908, p<
0.05; no consistent education pattern] while age was not [F(1,
501)¼ 7.5105, ns]. Hemisphere signiﬁcantly interacted with ROI
[F(1, 501) ¼ 2.727, p < 0.05] although this difference did not survive
Bonferroni correction. Based on these results, and previous reports
of a signiﬁcant association between age and gray matter thickness
or volume (Scahill et al., 2002; Seo et al., 2011; Skullerud,1984), all 3
demographic variables were included as covariates in all analyses of
group differences, and cortical thickness estimates in each ROI were
collapsed over the hemispheres. Post hoc 2-sided t tests were cor-
rected according to the Hochberg GT2 procedure for unequal
sample sizes. Signiﬁcance levels were corrected for multiple com-
parisons according to Bonferroni. All statistical analyses were per-
formed using SPSS 21.0 (IBM Corp Released 2012. IBM SPSS
Statistics for Windows, version 21.0, Armonk, NY, USA).
3. Results
3.1. Regional parahippocampal gyrus thinning in aMCI and AD
patients
Two-tailed, univariate ANCOVAs with sex, age, and education as
covariates were performed to determine whether each PHG ROI
was atrophied in the aMCI and AD groups relative to their corre-
sponding NC sample. Signiﬁcance was tested with Bonferroni-
corrected p-values (i.e., p ¼ 0.05/8 ¼ 0.00625). With respect tothe aMCI group, these revealed that the ERC and mPRC, but not the
lPRC and PHC, were signiﬁcantly atrophied in the aMCI group [ERC:
F(1,64) ¼ 13.259, p< 0.00625, mPRC: F(1,64) ¼ 10.587, p< 0.00625,
lPRC: F(1,64)¼ 4.544, p> 0.00625, PHC: F(1,64)¼ 3.496, p¼ 0.066].
A univariate ANCOVA with ERC versus mPRC ROI and diagnostic
category revealed that these structures were atrophied to similar
extents in the aMCI group [nonsigiﬁcant interaction; F(1, 131) ¼
0.011, p ¼ 0.916].
The AD versus NC comparison revealed that the ERC, mPRC, and
lPRC, but not the PHC, were signiﬁcantly atrophied in the AD group
[ERC: F(1,60) ¼ 52.650, p < 0.00625, mPRC: F(1,60) ¼ 39.726, p <
0.00625, lPRC: F(1,60) ¼ 8.243, p < 0.00625, PHC: F(1,60) ¼ 4.769,
p ¼ 0.033 < 0.05 i.e., did not survive Bonferroni correction of
0.00625]. Similar to the aMCI group, the extent of cortical thinning
(relative to NCs) in the AD’s ERC versus mPRC, as well as mPRC
versus lPRC did not differ [no signiﬁcant interaction of group and
ROI: ERC vs. mPRC: F(1, 123) ¼ 0.038, p ¼ 0.844; mPRC versus lPRC:
F(1, 123) ¼ 3.346, p ¼ 0.070]. However, atrophy in the ERC differed
signiﬁcantly from atrophy in the lPRC [F(1, 123) ¼ 4.229, p < 0.05].
The mean cortical thickness values for each ROI per group are
provided in Table 3.
3.2. Estimated progression of cortical thinning in very early AD
To estimate the progression of regional PHG thinning from aMCI
to AD stages, patients’ cortical thickness values were transformed
into standard (z-) scores based on the mean and standard deviation
of their respective demographically matched control group and
compared with 2-tailed, unpaired t tests. These analyses revealed
that ERC and mPRC signiﬁcantly differed between aMCI and AD
patients, while lPRC and PHC did not [ERC: t(55) ¼ 2.622, p < 0.05;
mPRC: t(55) ¼ 2.414, p < 0.05; lPRC: t(55) ¼ 0.750, p ¼ 0.456; PHC:
t(55) ¼ 0.155, p ¼ 0.878; see Fig. 1].
Fig. 1. Z-transformed mean thickness values for aMCI and AD participants for each ROI.
Standard error bars are displayed (1 SE). *Signiﬁcant differences at p < 0.05.
Abbreviations: AD, Alzheimer’s dementia; aMCI, amnestic mild cognitive impairment;
ERC, entorhinal cortex; lPRC, lateral perirhinal cortex; mPRC, medial perirhinal cortex;
PHC, parahippocampal cortex; ROI, region of interest; SE, standard error.
Table 4
MNI y-coordinates (coronal levels) maximally differentiating NC from very early AD
patients
ROI NC versus AD
Left hemisphere Right hemisphere
y-level (ES, SD) y-level (ES, SD)
ERC L3 (1.26, 0.082) 5 (1.06, 0.076)
L4 (1.01, 0.079) 6 (1.11, 0.074)
L5 (0.95, 0.082) 7 (1.08, 0.078)
mPRC 7 (0.86, 0.060) L7 (0.90, 0.067)
L8 (1.01, 0.058) L8 (0.93, 0.065)
Bolded text represents vertices of maximal differences in cortical thickness between
AD patients and healthy controls.
Key: AD, Alzheimer’s dementia; ERC, entorhinal cortex; ES, effect size; mPRC, medial
perirhinal cortex; NC, normal controls; ROI, region of interest; SD, standard
deviation.
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aMCI and AD patients
In the clinical setting, coronal slices of anatomic MRI scans are
examined for PHG thinning indicative of AD. The next analysis
aimed to determine whether ERC and mPRC thinning was dispro-
portionately manifested in speciﬁc coronal (MNI y-coordinate)
levels. To address this question, we compared normalized cortical
thickness values at each vertex coordinate of the NC versus ADTable 3
Normalized and retransformed mean cortical thicknesses in each ROI over both hemisph
Group
y ¼ 10 y ¼ 10
ERC mPRC
M (SD) M (SD)
NC versus aMCI
NC (n ¼ 46) 3.65 (0.29) 2.98 (0.36
aMCI (n ¼ 23) 3.37 (0.37) 2.71 (0.51
Relative difference (%) 8 9
NC versus AD
NC (n ¼ 31) 3.61 (0.33) 2.91 (0.35
AD (n ¼ 34) 2.95 (0.44) 2.27 (0.49
Relative difference (%) 18 22
M and SD, both values are displayed in mm and were transformed as described in Sectio
Key: AD, Alzheimer’s dementia; aMCI, amnestic mild cognitive impairment; ERC, entorhi
NC, normal controls; PHC, parahippocampal cortex; ROI, region of interest; SD, standardgroup. This analysis was conducted on y-levels containing mini-
mally 90%e95% of the distribution of data points, corresponding to
the mid anterior-to-posterior section (MNI y-levels between 22
and 3), to minimize spurious ﬁndings.
Two univariate ANOVAs, one for the mPRC and one for the ERC,
with mean normalized cortical thickness values at each y-level as
the dependent variable, and diagnosis, hemisphere and MNI
y-coordinate as independent variables, were conducted to deter-
mine whether cortical thinning (i.e., a difference between control
and patient thickness) was exacerbated at speciﬁc y-levels (i.e., a
signiﬁcant interaction between group and y-level). This was indeed
the case for both the ERC and mPRC: we found a 3-way interaction
between group, y-level, and hemisphere [ERC: F(19, 31,765)¼ 3.241,
p < 0.001; mPRC: F(19, 30,533) ¼ 2.703, p < 0.001]. Additional post
hoc tests identiﬁed the nature of these interactions, that is, that
maximal cortical thinning in the ERC and mPRC was constrained to
different y-levels in each hemisphere. Speciﬁcally, left hemisphere
ERC cortical thinning was maximal at y-levels 3 to 5, and in
levels 5 to 7 in the right hemisphere (Bonferroni-corrected
univariate ANCOVAs of NC vs. AD and left hemisphere y-levels (MNI
y-levels between 22 and 3): F(19, 16,221) ¼ 14.866, p < 0.0125;
same ANCOVA with right hemisphere y-levels: F(19, 165541) ¼
9.705, p< 0.0125). Maximal cortical thickness in the mPRC was also
evident at different anterior-to-posterior extents. In the lefteres
y ¼ 10 y ¼ 28
lPRC PHC
M (SD) M (SD)
) 3.24 (0.43) 2.65 (0.31)
) 3.08 (0.39) 2.55 (0.26)
5 4
) 3.23 (0.45) 2.61 (0.31)
) 2.90 (0.51) 2.45 (0.34)
10 6
n 2.3.
nal cortex; lPRC, lateral perirhinal cortex; M, mean; mPRC, medial perirhinal cortex;
deviation.
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found at y ¼ 8, whereas maximal differences in the right hemi-
sphere mPRC was speciﬁc to y-levels 7 and 8 [Bonferroni-
corrected univariate ANCOVAs of NC vs. AD and left hemisphere
y-levels (MNI y-levels between 22 and 3): F(19, 15,769) ¼ 2.590,
p < 0.0125; same ANCOVA with right hemisphere y-levels: F(19,
14,761) ¼ 4.195, p < 0.0125]. Table 4 summarizes these results by
indicating the MNI y-coordinates where NCs maximally differed
from AD patients (i.e., where p < 0.05 and effect size 0.3). To
illustrate the general patterns of atrophy, the distribution of cortical
thickness differences between NCs and AD patients in the ERC and
mPRC are plotted in Fig. 2. We note that although the maximal
difference in NC versus AD ERC cortical thickness was found in the
right hemisphere (cf. red portion of ERC difference, Fig. 2), the na-
ture of the variance at each y-level generated the largest statistical
difference in the left hemisphere ERC.Fig. 2. Differences in mean vertex-wise cortical thickness values between NC and AD partic
than patients, blue colors represent the opposite. Abbreviations: AD, Alzheimer’s dementia4. Discussion
Patients with aMCI evidence cortical thinning of the mPRC as
well as the ERC but neither the lPRC nor the PHC. However, the lPRC
was also signiﬁcantly atrophied in AD patients. The cortical thick-
ness of the PHC remained intact in the aMCI and AD patients. With
increasing clinical progression at this early stage (aMCI vs. early
AD), more impaired patients similarly showed signiﬁcantly thinner
mPRC’s and ERC’s. However, there were no signiﬁcant differences
with respect to the lPRC or PHC when comparing aMCI versus AD
patients. These ﬁndings based on rigorous anatomic segmentation
add new aspects to the literature on atrophy in AD by showing that
when patients in the earliest stages of AD are investigated, differ-
ential thinning can indeed be documented within ROIs of the PHG,
in contrast to negative results from previous reports (e.g., Dickerson
et al., 2009; Teipel et al., 2006). The present ﬁndings are relevant toipants. Red colors display areas where NCs show higher mean cortical thickness values
; NC, normal controls.
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cortical progression of NFT pathology and regional cortical thin-
ning, as well as the associated cognitive impairments predicted in
the earliest stages of the disease. Finally, the present ﬁndings
generate recommendations for the reliable and practical clinical
identiﬁcation of early AD-associated thinning on structural MRI
scans.
The staging of NFT-related pathology predicts that NFTs occur
ﬁrst in the mPRC followed by the ERC, and much later in the lPRC
(Braak and Braak, 1995). This stereotypical pattern of NFT pro-
gression is presumed to be accompanied with thinning in the
respective regions, although the precise mechanism relating NFT
pathology with cortical atrophy (and neuronal functioning) re-
mains to be determined. The present ﬁndings are broadly consis-
tent with this hypothesis: both mPRC and ERC demonstrated
thinning in both patient groups, whereas lPRC thickness was atro-
phied in the AD group only, a pattern which is generally consistent
with the spread of cortical neuroﬁbrillary pathology as described by
Braak and Braak (1991, 1995). However, we found no evidence that
the mPRC was atrophied to a greater extent than the ERC, as hy-
pothesized from the anatomic progression of NFT. Similar negative
ﬁndings were reported by other research groups (Dickerson et al.,
2001; Galton et al., 2001; Jack et al., 1997; Kordower et al., 2001;
Scahill et al., 2002; Xu et al., 2000), although these studies did
not segment the mPRC from the lPRC and investigated patients in
more advanced or variable stages of the disease. It seems that the
ERC and mPRC may show comparable relative thinning in the early
stages of AD. Because the ERC is thicker than the mPRC (e.g.,
Dickerson et al., 2009), the ERC would show greater absolute
change in thickness than the mPRC (e.g., a 10% reduction in a 4-mm
cortical thickness is a greater absolute change than a 10% reduction
in a 3 mm cortical thickness). However, thinning relative to region
size is expected to be comparable in both ROIs or greater in mPRC
than ERC in the earliest stages of the atrophy since the former
structure is affected ﬁrst (Braak et al., 1991, 1995). Indeed, we found
comparable or slightly greater relative decreases in patients’ mPRC
(9% and 22% for aMCI and AD patients, respectively) than their ERC
(8% and 18% for aMCI and AD patients, respectively). We note that
the estimates of relative ERC thinning are comparable to those re-
ported by Velayudhan et al. (2013) using the automatic ERC seg-
mentation tool provided by FreeSurfer (NC vs. MCI: 7%; NC vs. AD:
19%; present study: NC vs. aMCI: 8%; NC vs. AD: 18%). The avail-
ability of MRI processing software, which automatically and reliably
segments the ERC (Desikan et al., 2006; Fischl et al., 2002; Shaker
and Soltanian-Zadeh, 2008; Yushkevich et al., 2015) and recently
the mPRC (Augustinack et al., 2013), noticeably economizes the
segmentation process compared to manual segmentation. Howev-
er, the validity of the automatic mPRC segmentation remains to be
established, especially for complex (e.g., bifurcated) CS, although
very recent effort in this direction has been made (e.g., Yushkevich
et al., 2015).
Critically, the present study found no signiﬁcant PHC thinning in
the aMCI and AD groups. This ﬁnding contrasts with those reported
by Teipel et al. (2006) and Dickerson et al. (2009), both of whom
reported signiﬁcant PHC atrophy in their AD patients. However, the
patients investigated in these studies were in more advanced dis-
ease stages (meanMMSE score, 23.1 [lowest score, 10], respectively,
MMSE range, 16e28) compared to the present samples (MMSE
range 22e30). Correspondingly, Thangavel et al. (2008) report
substantial NFT load in layers III and V of areas TF (area fusiformis)
and TH (area temporohippocampica; corresponding with the PHC)
in postmortem brains of AD patients in presumably severe stages of
their disease (9e12 years disease duration). Thus, taken together,
the results of these and the present studies indicate that atrophy of
the mPRC and ERC occurs before atrophy of the PHC. Clearly,individuals in prodromal stages of the disease who are later
deﬁnitively diagnosed with Alzheimer’s disease must be longitu-
dinally studied to determine the ﬁrst cortical site of atrophy and the
longitudinal progression of atrophy in the PHG substructures.
Detailed vertex-vice investigations of cortical thickness values
revealed the coronal slices with maximal ERC and mPRC cortical
thinning in AD versus control participants, namely anterior slices
ranging from MNI y ¼ 3 to 8, that is, the region between 4 and
9 mm posterior to the most anterior slice where the amygdala is
ﬁrst visible. Although for ERC the most discriminative slices were
situated in the left hemisphere only, they were situated in both
hemispheres for mPRC. These ﬁndings can be applied in the clinical
setting to reliably detect ERC and mPRC thinning in potential very
early AD patients. To our knowledge, this is the ﬁrst study that
provides speciﬁc y-MNI coordinates that aim to support the process
of AD diagnosis in the clinical as well as the research setting.
The cognitive domains that appear to be affected in the earliest
stages of aMCI and AD using standard clinical neuropsychological
tests are verbal and visual episodic memory (Salmon, 2011). Indeed,
a recent study by Mistridis et al. (2015) demonstrates that verbal
memory performance declined already 8 years before the diagnosis
of MCI preceding AD (n ¼ 27) compared to 60 participants who
remained cognitively healthy. These neurocognitive functions are
strongly associated with the hippocampus and the ERC (Lipton and
Eichenbaum, 2008). The PRC, which is affected by NFT before the
ERC, has been associated with the processing of semantic object
memories and object recognition memory (Kivisaari et al., 2013b).
Although some studies report that these functions, whenmeasured
by the semantic ﬂuency test, decline ﬁrst or concurrently with
episodic memory (Amieva et al., 2005, 2008), most studies report
that decline in episodic memory precedes semantic memory
impairment (Grober et al., 2008; Saxton et al., 2004). However,
common clinical tests of semantic memory, such as semantic
ﬂuency, may not be sensitive enough to speciﬁc kinds of distur-
bances in semantic object processing associated with PRC
dysfunction that have been described in recent years (see e.g., Hirni
et al., 2013; Kivisaari et al., 2012, 2013a; Moss et al., 2005; Tyler
et al., 2004). More speciﬁc cognitive tasks based on cognitive
neuroscience models of PRC functioning should be developed to
take advantage of the progress made in this domain and translate it
to the clinical research setting. Therefore, measures of cortical
thickness can be applied most effectively as part of comprehensive
multimodal diagnostic assessment for AD including advanced
neuropsychological testing and where possible PET and/or MR
functional imaging.
The present results demonstrate that the mPRC and ERC are
atrophied in very early AD, whereas the thickness of the PHC re-
mains within normal limits. The lPRC was signiﬁcantly atrophied in
the AD, but not in the aMCI group. Studies investigating more
advanced AD patients demonstrate that all PHG substructuresdthe
PRC, ERC, and PHCdare comparably atrophic. Thus, the present
ﬁndings regarding mPRC and ERC thinning broadly map onto the
hierarchical progression of neuroﬁbrillary pathology described by
Braak and Braak (1991, 1995). Critically, they further suggest that
cognitive impairments associated with the PHC (e.g., dysfunctional
processing of visuospatial and landmark information) are still not
present in the earliest stages of the AD, whereas those related to
the mPRC and ERC represent promising cognitive markers of
incipient AD.Disclosure statement
The authors have nothing to disclose.
S. Krumm et al. / Neurobiology of Aging 38 (2016) 188e196 195Acknowledgements
This study was supported by grants from the Swiss National
Science Foundation (Ambizione fellowship PZ00P1_126493
[Kirsten I Taylor] and grant 3200-049107 [Andreas U Monsch]), the
Alfred and Anneliese Sutter-Stöttner Stiftung (Andreas U Monsch),
and Novartis Foundations, Basel (Andreas U Monsch), Switzerland.References
American Psychichiatric Association, 1994. Diagnostic and Statistical Manual of
Mental Disorders. American Psychiatric Press, Washington DC.
Amieva, H., Jacqmin-Gadda, H., Orgogozo, J.-M., Le Carret, N., Helmer, C.,
Letenneur, L., Barberger-Gateau, P., Fabrigoule, C., Dartigues, J.F., 2005. The 9
year cognitive decline before dementia of the Alzheimer type: a prospective
population-based study. Brain J. Neurol. 128, 1093e1101.
Amieva, H., Le Goff, M., Millet, X., Orgogozo, J.-M., Pérès, K., Barberger-Gateau, P.,
Jacqmin-Gadda, H., Dartigues, J.F., 2008. Prodromal Alzheimer’s disease: suc-
cessive emergence of the clinical symptoms. Ann. Neurol. 64, 492e498.
Augustinack, J.C., Huber, K.E., Stevens, A.A., Roy, M., Frosch, M.P., van der Kouwe, A.J.,
Wald, L.L., Van Leemput, K., McKee, A.C., Fischl, B., Alzheimer’s Disease Neuro-
imaging Initiative, 2013. Predicting the location of human perirhinal cortex,
Brodmann’s area 35, from MRI. Neuroimage 64, 32e42.
Ball, M.J., 1978. Topographic distribution of neuroﬁbrillary tangles and gran-
ulovacuolar degeneration in hippocampal cortex of aging and demented pa-
tients. A quantitative study. Acta Neuropathol. 42, 73e80.
Braak, H., Braak, E., 1985. On areas of transition between entorhinal allocortex and
temporal isocortex in the human brain. Normal morphology and lamina-
speciﬁc pathology in Alzheimer’s disease. Acta Neuropathol. 68, 325e332.
Braak, H., Braak, E., 1991. Neuropathological stageing of Alzheimer-related changes.
Acta Neuropathol. 82, 239e259.
Braak, H., Braak, E., 1995. Staging of Alzheimer’s disease-related neuroﬁbrillary
changes. Neurobiol. Aging 16, 271e284.
Braak, H., Del Tredici, K., 2006. Staging of cortical neuroﬁbrillary inclusions of the
Alzheimer’s type. In: Jucker, M., Beyreuther, K., Haass, C., Nitsch, R.M.,
Christen, Y. (Eds.), Alzheimer: 100 Years and beyond. Springer; Berlin Heidel-
berg, pp. 97e106.
Critchley, M., 1953. The parietal lobes, vii. Williams and Wilkins, Oxford, England.
Dale, A.M., Fischl, B., Sereno, M.I., 1999. Cortical surface-based analysis. I. Segmen-
tation and surface reconstruction. Neuroimage 9, 179e194.
Delis, D.C., Kramer, J.H., Kaplan, E., Ober, B.A., 1987. California Verbal Learning Test.
Psychological Corporation, San Antonio, Texas.
Desikan, R.S., Ségonne, F., Fischl, B., Quinn, B.T., Dickerson, B.C., Blacker, D.,
Buckner, R.L., Dale, A.M., Maguire, R.P., Hyman, B.T., Albert, M.S., Killiany, R.J.,
2006. An automated labeling system for subdividing the human cerebral cortex
on MRI scans into gyral based regions of interest. Neuroimage 31, 968e980.
Dickerson, B.C., Feczko, E., Augustinack, J., Pacheco, J., Morris, J., Fischl, B.,
Buckner, R., 2009. Differential effects of aging and Alzheimer’s disease on
medial temporal lobe cortical thickness and surface area. Neurobiol. Aging 30,
432e440.
Dickerson, B.C., Sullivan, M.P., Forchetti, C., Wilson, R.S., Bennett, D.A., Beckett, L.A.,
deToledo-Morrell, L., 2001. MRI-derived entorhinal and hippocampal atrophy in
incipient and very mild Alzheimer’s disease. Neurobiol. Aging 22, 747e754.
Du, A.T., Schuff, N., Amend, D., Laakso, M.P., Hsu, Y.Y., Jagust, W.J., Yaffe, K.,
Kramer, J.H., Reed, R., Norman, D., Chui, H.C., Weiner, M.W., 2001. Magnetic
resonance imaging of the entorhinal cortex and hippocampus in mild cognitive
impairment and Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry 71,
441e447.
Epstein, R., Kanwisher, N., 1998. A cortical representation of the local visual envi-
ronment. Nature 392, 598e601.
Fischl, B., Dale, A.M., 2000. Measuring the thickness of the human cerebral cortex
from magnetic resonance images. Proc. Natl. Acad. Sci. U. S. A. 97, 11050e11055.
Fischl, B., Salat, D.H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der
Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., Montillo, A., Makris, N.,
Rosen, B., Dale, A.M., 2002. Whole brain segmentation: automated labeling of
neuroanatomical structures in the human brain. Neuron 33, 341e355.
Folstein, M.F., Folstein, S.E., McHugh, P.R., 1975. “Mini Mental State”da practical
method for grading the cognitive state of patients for the clinician. J. Psychiatry
Res. 12, 189e198.
Galton, C.J., Patterson, K., Graham, K., Lambon, R., Williams, G., Antoun, N.,
Sahakian, B.J., Hodges, J.R., 2001. Differing patterns of temporal atrophy in
Alzheimer’s disease and semantic dementia. Neurology 57, 216e225.
Geddes, J.W., Tekirian, T.L., Soultanian, N.S., Ashford, J.W., Davis, D.G.,
Markesbery, W.R., 1997. Comparison of neuropathologic criteria for the diag-
nosis of Alzheimer’s disease. Neurobiol. Aging 18 (4, Supplement 1), 99e105.
Gómez-Isla, T., Hollister, R., West, H., Mui, S., Growdon, J.H., Petersen, R.C., Parisi, J.E.,
Hyman, B.T., 1997. Neuronal loss correlates with but exceeds neuroﬁbrillary
tangles in Alzheimer’s disease. Ann. Neurol. 41, 17e24.
Grober, E., Hall, C.B., Lipton, R.B., Zonderman, A.B., Resnick, S.M., Kawas, C., 2008.
Memory impairment, executive dysfunction, and intellectual decline in pre-
clinical Alzheimer’s disease. J. Int. Neuropsychol. Soc. 14, 266e278.Hanke, J., 1997. Sulcal pattern of the anterior parahippocampal gyrus in the human
adult. Ann. Anat. 179, 335e339.
Hirni, D.I., Monsch, A.U., Kivisaari, S.L., Reinhardt, J., Ulmer, S., Stippich, C.,
Taylor, K.I., 2013. Impaired medial perirhinal cortex functioning twelve years
preceding diagnosis of Alzheimer’s disease. Poster Present Annu Meet Soc
Neurosci, San Diego, USA.
Im, K., Lee, J.M., Seo, S.W., Hyung Kim, S., Kim, S.I., Na, D.L., 2008. Sulcal morphology
changes and their relationship with cortical thickness and gyral white matter
volume in mild cognitive impairment and Alzheimer’s disease. Neuroimage 43,
103e113.
Insausti, R., Juottonen, K., Soininen, H., Insausti, A.M., Partanen, K., Vainio, P.,
Laakso, M.P., Pitkänen, A., 1998. MR volumetric analysis of the human ento-
rhinal, perirhinal, and temporopolar cortices. Am. J. Neuroradiol. 19, 659e671.
Jack, C.R., Petersen, R.C., Xu, Y.C., Waring, S.C., O’Brien, P.C., Tangalos, E.G.,
Smith, G.E., Ivnik, R.J., Kokmen, E., 1997. Medial temporal atrophy on MRI in
normal aging and very mild Alzheimer’s disease. Neurology 49, 786e794.
Juottonen, K., Laakso, M.P., Insausti, R., Lehtovirta, M., Pitkänen, A., Partanen, K.,
Soininen, H., 1998. Volumes of the entorhinal and perirhinal cortices in Alz-
heimer’s disease. Neurobiol. Aging 19, 15e22.
Kaplan, E., Goodglass, H., Weintraub, S., Goodglass, H., 1983. Boston naming Test. Lea
& Febiger, Philadelphia.
Kivisaari, S.L., Monsch, A.U., Taylor, K.I., 2013a. False positives to confusable objects
predict medial temporal lobe atrophy. Hippocampus 9, 832e841.
Kivisaari, S.L., Probst, A., Taylor, K.I., 2013b. The perirhinal, entorhinal and para-
hippocampal cortices and hippocampus: an overview of functional anatomy
and protocol for their segmentation in MR images. In: Ulmer, S., Jansen, O.
(Eds.), fMRI: Basics and Clinical Application. Springer, Berlin, pp. 239e304.
Kivisaari, S.L., Tyler, L.K., Monsch, A.U., Taylor, K.I., 2012. Medial perirhinal cortex
disambiguates confusable objects. Brain 135, 3757e3769.
Kordower, J.H., Chu, Y., Stebbins, G.T., DeKosky, S.T., Cochran, E.J., Bennett, D.,
Mufson, E.J., 2001. Loss and atrophy of layer II entorhinal cortex neurons in
elderly people with mild cognitive impairment. Ann. Neurol. 49, 202e213.
Lerch, J.P., Pruessner, J.C., Zijdenbos, A., Hampel, H., Teipel, S.J., Evans, A.C., 2005.
Focal decline of cortical thickness in Alzheimer’s disease identiﬁed by compu-
tational neuroanatomy. Cereb. Cortex 15, 995e1001.
Lipton, P.A., Eichenbaum, H., 2008. Complementary roles of hippocampus and
medial entorhinal cortex in episodic memory. Neural Plast. 2008, 258467.
Mistridis, P., Krumm, S., Monsch, A.U., Berres, M., Taylor, K.I., 2015. The 12 years
preceding mild cognitive impairment due to Alzheimer’s disease: The temporal
emergence of cognitive decline. J. Alzheimers Dis. 48, 1095e1107.
Moss, H.E., Rodd, J.M., Stamatakis, E.A., Bright, P., Tyler, L.K., 2005. Anteromedial
temporal cortex supports ﬁne-grained differentiation among objects. Cereb.
Cortex 15, 616e627.
Nelson, P.T., Alafuzoff, I., Bigio, E.H., Bouras, C., Braak, H., Cairns, N.J., Castellani, R.J.,
Crain, B.J., Davies, P., Del Tredici, K., Duyckaerts, C., Frosch, M.P., Haroutunian, V.,
Hof, P.R., Hulette, C.M., Hyman, B.T., Iwatsubo, T., Jellinger, K.A., Jicha, G.A.,
Kövari, E., Kukull, W.A., Leverenz, J.A., Love, S., Mackenzie, I.R., Mann, D.M.,
Masliah, E., McKee, A.C., Montine, T.J., Morris, J.C., Schneider, J.A., Sonnen, J.A.,
Thal, D.R., Trojanowski, J.Q., Troncoso, J.C.,Wisniewski, T.,Woltjer, R.L., Beach, T.G.,
2012. Correlation of Alzheimer disease neuropathologic changes with cognitive
status: a review of the literature. J. Neuropathol. Exp. Neurol. 71, 362e381.
Petersen, R.C., Parisi, J.E., Dickson, D.W., Johnson, K.A., Knopman, D.S., Boeve, B.F.,
Jicha, G.A., Ivnik, R.J., Smith, G.E., Tangalos, E.G., Braak, H., Kokmen, E., 2006.
Neuropathologic features of amnestic mild cognitive impairment. Arch. Neurol.
63, 665e672.
Pruessner, J.C., Köhler, S., Crane, J., Pruessner, M., Lord, C., Byrne, A., Kabani, N.,
Collins, D.L., Evans, A.C., 2002. Volumetry of the temporopolar, perirhinal, en-
torhinal and parahippocampal cortex from high-resolution MRI images:
considering the variability of the collateral sulcus. Cereb. Cortex 12, 1342e1353.
Salmon, D.P., 2011. Neuropsychological features of mild cognitive impairment and
preclinical Alzheimer’s disease. Curr. Top Behav. Neurosci. 10, 187e212.
Saxton, J., Lopez, O.L., Ratcliff, G., Dulberg, C., Fried, L.P., Carlson, M.C., Newman, A.B.,
Kuller, L., 2004. Preclinical Alzheimer disease: neuropsychological test perfor-
mance 1.5 to 8 years prior to onset. Neurology 63, 2341e2347.
Scahill, R.I., Schott, J.M., Stevens, J.M., Rossor, M.N., Fox, N.C., 2002. Mapping the
evolution of regional atrophy in Alzheimer’s disease: unbiased analysis of ﬂuid-
registered serial MRI. Proc. Natl. Acad. Sci. U. S. A. 99, 4703e4707.
Seo, S.W., Im, K., Lee, J.-M., Kim, S.T., Ahn, H.J., Go, S.M., Kim, S.-H., Na, D.L., 2011.
Effects of demographic factors on cortical thickness in Alzheimer’s disease.
Neurobiol. Aging 32, 200e209.
Shaker, M., Soltanian-Zadeh, H., Automatic segmentation of brain structures from
MRI integrating atlas-based labeling and level set method. In: Canadian
Conference on Electrical and Computer Engineering. CCECE 2008; 2008. p.
1755e1758.
Skullerud, K., 1984. Variations in the size of the human brain. Inﬂuence of age, sex,
body length, body mass index, alcoholism, Alzheimer changes, and cerebral
atherosclerosis. Acta Neurol. Scand. Suppl. 102, 1e94.
Taylor, K.I., Probst, A., 2008. Anatomic localization of the transentorhinal region of
the perirhinal cortex. Neurobiol. Aging 29, 1591e1596.
Teipel, S.J., Pruessner, J.C., Faltraco, F., Born, C., Rocha-Unold, M., Evans, A., Möller, H.-
J., Hampel, H., 2006. Comprehensive dissection of the medial temporal lobe in
AD: measurement of hippocampus, amygdala, entorhinal, perirhinal and para-
hippocampal cortices using MRI. J. Neurol. 253, 794e800.
Thangavel, R., van Hoesen, G.W., Zaheer, A., 2008. Posterior parahippocampal gyrus
pathology in Alzheimer’s disease. Neuroscience 154, 667e676.
S. Krumm et al. / Neurobiology of Aging 38 (2016) 188e196196Tyler, L.K., Stamatakis, E.A., Bright, P., Acres, K., Abdallah, S., Rodd, J.M., Moss, H.E.,
2004. Processing objects at different levels of speciﬁcity. J. Cogn. Neurosci. 16,
351e362.
Van Hoesen, G.W., Augustinack, J.C., Dierking, J., Redman, S.J., Thangavel, R., 2000.
The parahippocampal gyrus in Alzheimer’s disease: clinical and preclinical
neuroanatomical correlates. Ann. N. Y. Acad. Sci. 911, 254e274.
Velayudhan, L., Proitsi, P., Westman, E., Muehlboeck, J.-S., Mecocci, P., Vellas, B.,
Tsolaki, M., K1oszewska, I., Soininen, H., Spenger, C., Hodges, A., Powell, J.,
Lovestone, S., Simmons, A., 2013. Entorhinal cortex thickness predicts cognitive
decline in Alzheimer’s disease. J. Alzheimers Dis. 33, 755e766.
Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L., Wahlund, L.-O.,
Nordberg, A., Bäckman, L., Albert, M., Almkvist, O., Arai, H., Basun, H.,Blennow, K., De Leon, M., Decarli, C., Erkinjuntti, T., Giacobini, E., Graff, C.,
Hardy, J., Jack, C., Jorm, A., Ritchie, K., Van Duijn, C., Visser, P., Petersen, R.C.,
2004. Mild cognitive impairmentdbeyond controversies, toward a consensus:
report of the International Working Group on Mild Cognitive Impairment.
J. Intern. Med. 256, 240e246.
Xu, Y., Jack, C.R., O’Brien, P.C., Kokmen, E., Smith, G.E., Ivnik, R.J., Boeve, B.F.,
Tangalos, R.G., Petersen, R.C., 2000. Usefulness of MRI measures of entorhinal
cortex versus hippocampus in AD. Neurology 54, 1760e1767.
Yushkevich, P.A., Pluta, J.B., Wang, H., Xie, L., Ding, S.-L., Gertje, E.C., Mancuso, L.,
Kliot, D., Das, S.R., Wolk, D.A., 2015. Automated volumetry and regional thick-
ness analysis of hippocampal subﬁelds and medial temporal cortical structures
in mild cognitive impairment. Hum. Brain Mapp. 36, 258e287.
